Autism Spectrum Disorder Trial, Recruiting NCT05681923 Sponsor: University Hospital, Montpellier Condition: Autism Spectrum Disorder
Back to Autism Spectrum Disorder

Autism Spectrum Disorder Trial, Recruiting

NCT05681923
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For the mother:

  • You are currently pregnant (with one or more babies) and are at least 16 weeks along.
  • You have at least one biological child who is 24 months old or older.
  • You are at least 18 years old.

For the father:

  • You are the biological father of the unborn child.
  • You are at least 18 years old.

For the unborn child:

  • The mother is taking part in the study.

Additional requirements for the "High Risk" group (families who already have a child with autism):

  • There is a biological child of the mother and/or father who is between 24 months and 18 years old and has a confirmed autism diagnosis.
  • If there are several children in the family with autism, only the youngest one with autism would be considered for the study.
  • A child conceived through assisted reproduction (such as IVF) may still qualify, as long as they share some genetic heritage with the mother or father of the unborn child (confirm with trial site).
  • If the father does not live with the mother, his participation is not required, and the rest of the family can still take part.

Who may not be able to join:

  • You are unable to understand French or complete the study questionnaires.
  • You are under guardianship, curatorship, or any other legal protection measure, or your freedom has been restricted by a legal or administrative decision.
  • You are not registered with a social security system.
  • You do not wish to give consent to participate (parental consent is also required for any children involved).
  • You live too far from the study centre to attend follow-up appointments.

Additional exclusion for the "Low Risk" group only:

  • The mother or father already has a biological child who has been diagnosed with autism or any other neurodevelopmental condition.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 4 67 33 63 83

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
19 April 2023
Est. completion
1 March 2034

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Autism Spectrum Disorder diagnosis; Autism Spectrum Disorder diagnosis; Developmental Intelligence Disorder diagnosis; Developmental Coordination Disorder diagnosis; Attention Deficit Hyperactivity Disorder diagnosis; Diagnosis of Language and Learning Disorder; Socioeconomic and lifestyle risk factors for neurodevelopmental disorders including autism spectrum disorder; Maternal diet and medication use during pregnancy; Environmental exposition

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov